| Stage | STZ | % of rev | KO | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $2.6B | 100.00% | $13.4B | 100.00% | KO ×5.08 |
| Gross profit | $1.4B | 52.91% | $8.4B | 63.15% | KO +10.2pp |
| Operating income | $805M | 30.57% | $4.5B | 33.37% | KO +2.8pp |
| Pre-tax income | $729M | 27.70% | $4.8B | 36.12% | KO +8.4pp |
| Net income | $582M | 22.12% | $4.1B | 30.31% | KO +8.2pp |
| Stage | STZ | KO | Gap · A − B |
|---|---|---|---|
| Revenue | $2.6B100.00% | $13.4B100.00% | KO ×5.08 |
| Gross profit | 52.91%$1.4B | 63.15%$8.4B | KO +10.2pp |
| Operating income | 30.57%$805M | 33.37%$4.5B | KO +2.8pp |
| Pre-tax income | 27.70%$729M | 36.12%$4.8B | KO +8.4pp |
| Net income |
| 22.12%$582M |
| 30.31%$4.1B |
| KO +8.2pp |
No shared counterparties.